Why TNDM Stock Rose 14.6% on Nov 13, 2026
as of yesterday, 4:31 PM ET
The reason we found
Health Canada Expands Tandem’s Insulin Pump Approvals
Health Canada approved expanded use of Tandem’s t:slim X2 insulin pump with Control-IQ+ technology, including compatibility with Abbott’s FreeStyle Libre 3 Plus sensor and use during pregnancy. The broader indications and added sensor compatibility could improve the product’s commercial reach, plausibly driving today’s sharp gain.
regulatory approvalhigh confidence
Sources 2
Our call
Buy moredated Nov 13, 2026
Tandem Diabetes Care's report on Nov 5 beat profit forecasts by 63%, and its sales grew 6.8% over the past year. We'd stop buying if Tandem Diabetes Care's next report shows sales shrinking or misses profit forecasts.
Other moves on Nov 13
- SPCE−31.1%Virgin Galactic tumbles on financing plans and delayed flights
- MOD+27.9%Samsung Acquisition Talks Send Modine Shares Surging
- NU+11.7%Nu Holdings jumps after record profit and strong Q3 growth
- CBRS+11.1%Strong earnings and Microsoft deal lift Cerebras shares
- NBIS−10.0%Nebius selloff reflects higher spending and weaker near-term outlook
- SLS+9.8%SELLAS Advances Toward Transformative AML Trial Results